Cargando…
MDB-19. MULTIOMIC PROFILING OF MEDULLOBLASTOMA REVEALS SUBTYPE-SPECIFIC TARGETABLE ALTERATIONS AT THE PROTEOME AND N-GLYCAN LEVEL
Medulloblastomas (MBs) are malignant pediatric brain tumors which are clinically and histologically very heterogeneous. Epigenomic and transcriptomic analyses have advanced the understanding of these tumors and four main molecular subgroups – which themselves comprise several subtypes- have been def...
Autores principales: | Godbole, Shweta, Voss, Hannah, Schlumbohm, Simon, Schumann, Yannis, Peng, Bojia, Mynarek, Martin, Rutkowski, Stefan, Dottermusch, Matthias, Dorostkar, Mario M, Koshunov, Andrey, Mair, Thomas, Pfister, Stefan M, Neumann, Philipp, Hartmann, Christian, Weis, Joachim, Liesche-Starnecker, Friederike, Guan, Yudong, Schlüter, Hartmut, Schüller, Ulrich, Krisp, Christoph, Neumann, Julia E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259889/ http://dx.doi.org/10.1093/neuonc/noad073.252 |
Ejemplares similares
-
MDB-15. CLINICAL CHARACTERISTICS AND OUTCOME OF CHILDHOOD LI-FRAUMENI SYNDROME MEDULLOBLASTOMA PATIENTS
por: Kolodziejczak, Anna, et al.
Publicado: (2023) -
MDB-28. DEEP LEARNING-BASED PERSONALIZED SURVIVAL PREDICTION FOR MEDULLOBLASTOMA
por: Stefan, Sabina, et al.
Publicado: (2023) -
MDB-29. MEDULLOBLASTOMA SUBGROUP-SPECIFIC CHROMATIN STATES REVEAL NOVEL THERAPEUTIC VULNERABILITIES
por: Tao, Ran, et al.
Publicado: (2023) -
MDB-16. TARGETING EPIGENETIC DYSREGULATION IN PAEDIATRIC BRAIN TUMOURS
por: Badodi, Sara, et al.
Publicado: (2023) -
MDB-42. UNCOVERING DYNAMIC CHANGES IN MEDULLOBLASTOMA ASSOCIATED VASCULATURE IN ZEBRAFISH
por: Morris, Elysse, et al.
Publicado: (2023)